Epidemiological/JJ
and/CC
Genome-Wide/NN
Association/NN
Study/NN
of/IN
Gastritis/NN
or/CC
Gastric/JJ
Ulcer/NN
in/IN
Korean/JJ
Populations/NNS
./.
====================
Gastritis/NN
is/VBZ
a/DT
major/JJ
disease/NN
that/DT
has/VBZ
the/DT
potential/JJ
to/TO
grow/VB
as/IN
gastric/JJ
cancer/NN
./.
====================
Gastric/JJ
cancer/NN
is/VBZ
a/DT
very/RB
common/JJ
cancer/NN
,/,
and/CC
it/PRP
is/VBZ
related/JJ
to/TO
a/DT
very/RB
high/JJ
mortality/NN
rate/NN
in/IN
Korea/NN
./.
====================
This/DT
disease/NN
is/VBZ
known/VBN
to/TO
have/VB
various/JJ
reasons/NNS
,/,
including/VBG
infection/NN
with/IN
Helicobacter/NN
pylori/NN
,/,
dietary/JJ
habits/VBZ
,/,
tobacco/NN
,/,
and/CC
alcohol/NN
./.
====================
The/DT
incidence/NN
rate/NN
of/IN
gastritis/NN
has/VBZ
reported/VBN
to/TO
differ/VB
between/IN
age/NN
,/,
population/NN
,/,
and/CC
gender/NN
./.
====================
However/RB
,/,
unlike/IN
other/JJ
factors/NNS
,/,
there/EX
has/VBZ
been/VBN
no/DT
analysis/NN
based/VBN
on/IN
gender/NN
./.
====================
So/RB
,/,
we/PRP
examined/VBD
the/DT
high/JJ
risk/NN
factors/NNS
of/IN
gastritis/NN
in/IN
each/DT
gender/NN
in/IN
the/DT
Korean/JJ
population/NN
by/IN
focusing/VBG
on/IN
sex/NN
./.
====================
We/PRP
performed/VBD
an/DT
analysis/NN
of/IN
120/CD
clinical/JJ
characteristics/NNS
and/CC
genome-wide/NN
association/NN
studies/NNS
(/(
GWAS/NN
)/)
using/VBG
349,184/CD
single-nucleotide/JJ
polymorphisms/NNS
from/IN
the/DT
results/NNS
of/IN
Anseong/JJ
and/CC
Ansan/NN
cohort/NN
study/NN
in/IN
the/DT
Korea/NN
Association/NN
Resource/NN
(/(
KARE/NN
)/)
project/VBP
./.
====================
As/IN
the/DT
result/NN
,/,
we/PRP
could/MD
not/RB
prove/VB
a/DT
strong/JJ
relation/NN
with/IN
these/DT
factors/NNS
and/CC
gastritis/NN
or/CC
gastric/JJ
ulcer/NN
in/IN
the/DT
GWAS/NN
./.
====================
However/RB
,/,
we/PRP
confirmed/VBD
several/JJ
already-known/RB
risk/NN
factors/NNS
and/CC
also/RB
found/VBD
some/DT
differences/NNS
of/IN
clinical/JJ
characteristics/NNS
in/IN
each/DT
gender/NN
using/VBG
logistic/JJ
regression/NN
./.
====================
As/IN
a/DT
result/NN
of/IN
the/DT
logistic/JJ
regression/NN
,/,
a/DT
relation/NN
with/IN
hyperlipidemia/NN
,/,
coronary/JJ
artery/RB
disease/NN
,/,
myocardial/JJ
infarction/NN
,/,
hyperlipidemia/NN
therapy/NN
,/,
hypotensive/JJ
or/CC
antihypotensive/JJ
drug/NN
,/,
diastolic/JJ
blood/NN
pressure/NN
,/,
and/CC
gastritis/NN
was/VBD
seen/VBN
in/IN
males/NNS
;/:
the/DT
results/NNS
of/IN
this/DT
study/NN
suggest/VBP
that/IN
vascular/JJ
disease/NN
has/VBZ
a/DT
potential/JJ
association/NN
with/IN
gastritis/NN
in/IN
males/NNS
./.
====================
Gastric/JJ
cancer/NN
is/VBZ
a/DT
common/JJ
cancer/NN
type/NN
./.
====================
In/IN
the/DT
world/NN
,/,
this/DT
cancer/NN
type/NN
has/VBZ
the/DT
second/JJ
highest/JJS
incidence/NN
among/IN
males/NNS
and/CC
third/JJ
highest/JJS
among/IN
females/NNS
[/(
1/CD
]/)
./.
====================
In/IN
Korea/NN
,/,
the/DT
incidence/NN
rate/NN
of/IN
gastric/JJ
cancer/NN
was/VBD
second/JJ
highest/JJS
,/,
and/CC
the/DT
mortality/NN
rate/NN
of/IN
gastric/JJ
cancer/NN
was/VBD
third/JJ
highest/JJS
among/IN
all/DT
cancer/NN
types/NNS
in/IN
a/DT
2010/CD
Korean/JJ
cancer/NN
statistics/NNS
study/NN
[/(
2/CD
]/)
./.
====================
The/DT
incidence/NN
rate/NN
of/IN
gastric/JJ
cancer/NN
differs/VBZ
between/IN
patient/NN
age/NN
,/,
location/NN
,/,
and/CC
even/RB
sex/NN
[/(
3/CD
]/)
,/,
because/IN
gastric/JJ
cancer/NN
has/VBZ
various/JJ
subtypes/NNS
[/(
3/CD
,/,
4/CD
]/)
and/CC
a/DT
lot/JJ
of/IN
risk/NN
factors/NNS
[/(
5/CD
]/)
./.
====================
Helicobacter/RB
pylori/NN
is/VBZ
known/VBN
for/IN
having/VBG
a/DT
relation/NN
with/IN
gastric/JJ
cancer/NN
[/(
6/CD
]/)
./.
====================
Almost/RB
all/DT
gastric/JJ
cancer/NN
patients/NNS
are/VBP
infected/VBN
with/IN
H./NNP
pylori/NN
[/(
3/CD
]/)
./.
====================
As/IN
known/VBN
before/IN
,/,
dietary/JJ
habits/VBZ
also/RB
have/VBP
the/DT
potential/JJ
to/TO
affect/VB
gastric/JJ
cancer/NN
[/(
1/CD
]/)
./.
====================
The/DT
incidence/NN
risk/NN
factors/NNS
have/VBP
differences/NNS
in/IN
gastric/JJ
cancer/NN
or/CC
peptic/JJ
ulcers/NNS
by/IN
blood/NN
type/NN
[/(
7/CD
]/)
and/CC
sex/NN
[/(
8/CD
]/)
./.
====================
Gastric/JJ
cancer/NN
type/NN
also/RB
depends/VBZ
on/IN
patient/NN
populations/NNS
or/CC
race/NN
[/(
5/CD
]/)
./.
====================
So/RB
,/,
an/DT
analysis/NN
is/VBZ
needed/VBN
to/TO
find/VB
known/VBN
and/CC
unknown/JJ
risk/NN
factors/NNS
in/IN
diverse/JJ
phenotypes/NNS
[/(
3/CD
]/)
./.
====================
Gastritis/NN
is/VBZ
related/JJ
with/IN
gastric/JJ
cancer/NN
./.
====================
Chronic/JJ
gastric/JJ
inflammation/NN
has/VBZ
the/DT
potential/JJ
to/TO
grow/VB
into/IN
gastric/JJ
cancer/NN
[/(
9/CD
]/)
./.
====================
Many/JJ
risk/NN
factors/NNS
are/VBP
related/JJ
with/IN
gastritis/NN
,/,
as/IN
already/RB
reported/VBN
./.
====================
However/RB
,/,
even/RB
though/IN
gender/NN
is/VBZ
known/VBN
to/TO
be/VB
associated/VBN
with/IN
gastritis/NN
infraction/NN
,/,
there/EX
is/VBZ
not/RB
much/RB
information/NN
about/IN
the/DT
effects/NNS
on/IN
gastritis/NN
depending/VBG
on/IN
gender/NN
./.
====================
So/RB
,/,
we/PRP
examined/VBD
Korean/NN
risk/NN
factors/NNS
of/IN
gastritis/NN
and/CC
gastric/JJ
ulcer/NN
using/VBG
genotypes/NNS
and/CC
clinical/JJ
characteristics/NNS
of/IN
patients/NNS
who/WP
were/VBD
diagnosed/VBN
with/IN
gastritis/NN
or/CC
gastric/JJ
ulcer/NN
in/IN
each/DT
gender/NN
./.
====================
For/IN
revealing/VBG
the/DT
correlation/NN
with/IN
gastritis/NN
and/CC
known/VBN
and/CC
unknown/JJ
risk/NN
factors/NNS
,/,
we/PRP
analyzed/VBD
single-nucleotide/IN
polymorphisms/NNS
(/(
SNPs/NNS
)/)
and/CC
epidemiological/JJ
data/NNS
of/IN
the/DT
Korea/NN
Association/NN
Resource/NN
(/(
KARE/NN
)/)
project/VBP
,/,
which/WDT
comprised/VBD
the/DT
results/NNS
of/IN
the/DT
Anseong/JJ
and/CC
Ansan/NN
cohorts/NNS
study/NN
./.
====================
Clinical/JJ
characteristics/NNS
and/CC
study/NN
genotypes/VBZ
====================
This/DT
study/NN
analyzed/VBD
cohort/NN
data/NNS
that/WDT
comprised/VBD
the/DT
Anseong/JJ
and/CC
Ansan/NN
population/NN
study/NN
in/IN
the/DT
KARE/NN
projects/NNS
./.
====================
Anseong/JJ
is/VBZ
a/DT
rural/JJ
area/NN
,/,
and/CC
Ansan/NN
is/VBZ
a/DT
city/NN
./.
====================
Both/DT
areas/NNS
are/VBP
in/IN
Gyeonggi-do/NN
./.
====================
Citizen/NN
of/IN
these/DT
two/CD
cities/NNS
have/VBP
different/JJ
lifestyles/NNS
,/,
and/CC
they/PRP
are/VBP
exposed/VBN
to/TO
different/JJ
environment/NN
./.
====================
Detailed/JJ
information/NN
of/IN
the/DT
KARE/NN
data/NNS
was/VBD
reported/VBN
[/(
10/CD
]/)
./.
====================
The/DT
KARE/NN
data/NNS
included/VBD
8,842/CD
individuals/NNS
,/,
352,228/CD
SNPs/NNS
,/,
and/CC
277/CD
phenotypes/NNS
./.
====================
Among/IN
8,842/CD
total/JJ
individuals/NNS
,/,
we/PRP
divided/VBD
patients/NNS
and/CC
normal/JJ
subjects/NNS
for/IN
a/DT
control/JJ
and/CC
case/NN
study/NN
using/VBG
a/DT
positive/JJ
diagnosis/NN
experience/VBP
of/IN
gastritis/NN
./.
====================
There/EX
were/VBD
1,885/CD
patients/NNS
and/CC
6,957/CD
normal/JJ
subjects/NNS
./.
====================
First/RB
,/,
for/IN
selecting/VBG
the/DT
case/NN
,/,
we/PRP
eliminated/VBD
104/CD
patients/NNS
who/WP
were/VBD
diagnosed/VBN
under/IN
age/NN
20/CD
or/CC
had/VBD
unknown/JJ
age/NN
./.
====================
Then/RB
,/,
1,781/CD
patients/NNS
remained/VBD
./.
====================
Of/IN
these/DT
,/,
804/CD
patients/NNS
were/VBD
men/NNS
,/,
and/CC
977/CD
patients/NNS
were/VBD
women/NNS
./.
====================
Of/IN
6,957/CD
normal/JJ
subjects/NNS
,/,
no/DT
one/CD
was/VBD
aged/JJ
under/IN
20/CD
;/:
3,335/CD
were/VBD
men/NNS
,/,
and/CC
3,622/CD
were/VBD
women/NNS
./.
====================
Among/IN
352,228/CD
SNPs/NNS
,/,
we/PRP
excluded/VBD
3,044/CD
SNPs/NNS
based/VBN
on/IN
the/DT
Hardy-Weinberg/JJ
equilibrium/NN
test/NN
for/IN
quality/NN
control/NN
./.
====================
After/IN
frequency/NN
and/CC
genotyping/VBG
pruning/VBG
,/,
349,184/CD
SNPs/NNS
remained/VBD
./.
====================
Among/IN
277/CD
total/JJ
phenotypes/NNS
,/,
we/PRP
filtered/VBD
missing/VBG
phenotypes/NNS
and/CC
low/JJ
genotyping/VBG
rates/NNS
./.
====================
Then/RB
,/,
120/CD
clinical/JJ
characteristics/NNS
remained/VBD
./.
====================
We/PRP
also/RB
eliminated/VBD
gastritis/NN
phenotype/NN
variables/NNS
and/CC
unknown/JJ
drug/NN
information/NN
variables/NNS
;/:
101/CD
clinical/JJ
characteristics/NNS
remained/VBD
./.
====================
Statistical/JJ
analysis/NN
====================
For/IN
data/NNS
filtering/VBG
and/CC
finding/NN
significant/JJ
SNPs/NNS
,/,
we/PRP
used/VBD
PLINK/NN
version/NN
1.07/CD
,/,
that/DT
is/VBZ
a/DT
tool/NN
made/VBD
for/IN
analyzing/VBG
whole-genome/DT
association/NN
using/VBG
computational/JJ
methods/NNS
[/(
11/CD
]/)
./.
====================
We/PRP
used/VBD
the/DT
default/NN
options/NNS
of/IN
PLINK/NN
[/(
11/CD
]/)
,/,
and/CC
we/PRP
analyzed/VBD
phenotypes/NNS
by/IN
logistic/JJ
regression/NN
test/NN
for/IN
classifying/VBG
patients/NNS
and/CC
normal/JJ
subjects/NNS
and/CC
estimating/VBG
factors/NNS
./.
====================
We/PRP
also/RB
assessed/VBN
the/DT
result/NN
factors/NNS
of/IN
the/DT
logistic/JJ
regression/NN
by/IN
Student/JJ
's/POS
t-test/JJS
for/IN
revealing/VBG
meaningful/JJ
differences/NNS
between/IN
patients/NNS
and/CC
normal/JJ
subjects/NNS
using/VBG
R/NN
version/NN
3.0.2/CD
for/IN
finding/NN
gastritis-associated/VBN
factors/NNS
./.
====================
Then/RB
,/,
we/PRP
used/VBD
the/DT
receiver/NN
operating/VBG
characteristic/JJ
(/(
ROC/NN
)/)
curve/VBP
and/CC
area/NN
under/IN
the/DT
curve/JJ
(/(
AUC/NN
)/)
scores/VBZ
to/TO
confirm/VB
the/DT
prediction/NN
ability/NN
of/IN
the/DT
factors/NNS
./.
====================
Clinical/JJ
characteristics/NNS
====================
Tables/NNS
1/CD
and/CC
2/CD
explain/VBP
the/DT
results/NNS
of/IN
the/DT
logistic/JJ
regression/NN
test/NN
among/IN
total/JJ
clinical/JJ
characteristics/NNS
in/IN
each/DT
gender/NN
./.
====================
There/EX
were/VBD
differences/NNS
in/IN
gender-specific/JJ
clinical/JJ
characteristics/NNS
./.
====================
Among/IN
1,781/CD
total/JJ
patients/NNS
,/,
977/CD
patients/NNS
and/CC
804/CD
patients/NNS
were/VBD
male/JJ
and/CC
female/JJ
,/,
respectively/RB
./.
====================
Patients/NNS
had/VBD
several/JJ
disease-association/NN
factors/NNS
in/IN
both/DT
genders/NNS
:/:
area/NN
,/,
positive/JJ
diagnosis/NN
of/IN
hyperlipidemia/NN
,/,
positive/JJ
diagnosis/NN
of/IN
mental/JJ
disease/NN
,/,
continual/JJ
use/NN
of/IN
one/CD
or/CC
more/RBR
drugs/NNS
,/,
waist/NN
,/,
and/CC
height/RB
./.
====================
Through/IN
previous/JJ
studies/NNS
,/,
how/WRB
these/DT
factors/NNS
are/VBP
related/JJ
with/IN
gastritis/NN
was/VBD
verified/VBN
./.
====================
The/DT
incidence/NN
of/IN
gastritis/NN
is/VBZ
affected/VBN
by/IN
population/NN
,/,
geographic/JJ
variation/NN
,/,
or/CC
lifestyle/JJ
[/(
1/CD
,/,
5/CD
]/)
./.
====================
In/IN
this/DT
study/NN
,/,
we/PRP
used/VBD
cohort/JJ
data/NNS
that/WDT
comprised/VBD
country/NN
and/CC
city/NN
populations/NNS
./.
====================
As/IN
shown/VBN
Tables/NNS
1/CD
and/CC
2/CD
,/,
in/IN
both/CC
genders/NNS
,/,
the/DT
population/NN
of/IN
local/JJ
A/NN
had/VBD
a/DT
higher/JJR
gastritis/NN
incidence/NN
rate/NN
./.
====================
This/DT
means/NNS
that/DT
differences/NNS
in/IN
patient/NN
lifestyle/JJ
and/CC
environment/NN
affect/VB
the/DT
disease/NN
incidence/NN
rate/NN
./.
====================
It/PRP
is/VBZ
well/RB
known/VBN
that/IN
stress/NN
has/VBZ
an/DT
influence/NN
on/IN
carcinogenesis/NN
./.
====================
A/DT
study/NN
reported/VBD
that/IN
gastritis/NN
is/VBZ
closely/RB
connected/VBD
with/IN
mental/JJ
illness/NN
[/(
12/CD
]/)
and/CC
differs/VBZ
in/IN
degree/NN
according/VBG
to/TO
drug/NN
use-taking/VBG
medicine/NN
affects/VBZ
the/DT
stomach/NN
./.
====================
Nonsteroidal/JJ
anti-inflammatory/JJ
drugs/NNS
can/MD
cause/VB
gastrointestinal/JJ
damage/NN
[/(
13/CD
]/)
./.
====================
Losing/VBG
appetite/JJ
is/VBZ
the/DT
one/CD
of/IN
phenotypes/NNS
of/IN
gastritis/NN
that/DT
are/VBP
connected/VBN
with/IN
waist/NN
size/NN
or/CC
hip/NN
size/NN
as/IN
gastritisassociated/VBN
factors/NNS
./.
====================
However/RB
,/,
definite/JJ
evidence/NN
is/VBZ
lacking/VBG
[/(
14/CD
]/)
./.
====================
As/IN
shown/VBN
in/IN
Tables/NNS
1/CD
and/CC
2/CD
,/,
we/PRP
can/MD
explain/VB
the/DT
associative/JJ
relation/NN
that/DT
waist/VBP
size/NN
or/CC
hip/NN
size/NN
is/VBZ
smaller/JJR
despite/IN
patients/NNS
being/VBG
taller/NN
than/IN
normal/JJ
./.
====================
Also/RB
,/,
height/RB
is/VBZ
considered/VBN
to/TO
be/VB
a/DT
gastritis/NN
risk/NN
factor/NN
./.
====================
As/IN
shown/VBN
in/IN
a/DT
previous/JJ
study/NN
,/,
higher/JJR
height/NN
tends/NNS
to/TO
increase/VB
the/DT
gastric/JJ
cancer/NN
incidence/NN
rate/NN
[/(
15/CD
]/)
./.
====================
In/IN
males/NNS
and/CC
females/NNS
,/,
hyperlipidemia/NN
and/CC
gastritis/NN
are/VBP
related/JJ
with/IN
gastritis/NN
./.
====================
Only/RB
male/JJ
cases/NNS
are/VBP
associated/VBN
with/IN
vascular/JJ
disease/NN
./.
====================
Coronary/NN
artery/NN
has/VBZ
the/DT
potential/JJ
to/TO
grow/VB
into/IN
myocardial/JJ
infarction/NN
[/(
16/CD
]/)
,/,
and/CC
myocardial/JJ
infarction/NN
is/VBZ
related/JJ
with/IN
blood/NN
pressure/NN
[/(
17/CD
]/)
./.
====================
As/IN
previously/RB
reported/VBD
,/,
approximately/RB
30/CD
%/NN
of/IN
patients/NNS
with/IN
coronary/JJ
heart/NN
disease/NN
suffer/VBP
from/IN
hyperlipidemia/NN
at/IN
the/DT
same/JJ
time/NN
[/(
18/CD
]/)
./.
====================
So/RB
,/,
hyperlipidemia/NN
,/,
coronary/JJ
artery/NN
,/,
and/CC
myocardial/JJ
infarction/NN
are/VBP
all/DT
related/JJ
to/TO
each/DT
other/JJ
./.
====================
As/IN
shown/VBN
in/IN
Table/JJ
1/CD
,/,
in/IN
males/NNS
,/,
by/IN
logistic/JJ
regression/NN
,/,
there/EX
is/VBZ
a/DT
relation/NN
with/IN
hyperlipidemia/NN
,/,
coronary/JJ
artery/NN
,/,
myocardial/JJ
infarction/NN
,/,
hyperlipidemia/NN
therapy/NN
,/,
hypotensive/JJ
or/CC
antihypotensive/JJ
drug/NN
use/NN
,/,
and/CC
diastolic/JJ
blood/NN
pressure/NN
./.
====================
This/DT
relation/NN
is/VBZ
more/RBR
remarkable/JJ
in/IN
males/NNS
than/IN
in/IN
females/NNS
./.
====================
Repeatedly/RB
,/,
it/PRP
can/MD
be/VB
considered/VBN
that/IN
vascular/JJ
disease/NN
is/VBZ
connected/VBN
with/IN
gastritis/NN
./.
====================
In/IN
fact/NN
,/,
in/IN
this/DT
study/NN
,/,
including/VBG
males/NNS
and/CC
females/NNS
,/,
16/CD
patients/NNS
had/VBD
gastritis/NN
and/CC
myocardial/JJ
infarction/NN
(/(
20/CD
%/NN
)/)
,/,
77/CD
patients/NNS
had/VBD
gastritis/NN
and/CC
hyperlipidemia/NN
(/(
36/CD
%/NN
)/)
,/,
and/CC
13/CD
patients/NNS
had/VBD
gastritis/NN
and/CC
coronary/JJ
artery/NN
(/(
25.5/CD
%/NN
)/)
./.
====================
Female/JJ
patients/NNS
with/IN
gastritis/NN
have/VBP
4/CD
more/RBR
gastritis-associated/JJ
factors/NNS
by/IN
logistic/JJ
regression/NN
test/NN
compared/VBN
with/IN
males/NNS
./.
====================
In/IN
the/DT
case/NN
of/IN
taking/VBG
osteoporosis/NN
medicine/NN
,/,
the/DT
incidence/NN
rate/NN
is/VBZ
1.7/CD
times/NNS
higher/JJR
compared/VBN
with/IN
normal/JJ
./.
====================
Taking/VBG
anticonvulsants/NNS
is/VBZ
a/DT
meaningful/JJ
factor/NN
by/IN
logistic/JJ
regression/NN
test/NN
,/,
but/CC
few/JJ
patients/NNS
were/VBD
taking/VBG
this/DT
medicine/NN
[/(
4/CD
]/)
;/:
so/RB
,/,
it/PRP
is/VBZ
hard/RB
to/TO
prove/VB
that/IN
taking/VBG
anticonvulsants/NNS
has/VBZ
a/DT
positive/JJ
relation/NN
with/IN
gastritis/NN
./.
====================
Patients/NNS
who/WP
were/VBD
diagnosed/VBN
with/IN
tuberculosis/NN
and/CC
patients/NNS
who/WP
have/VBP
taken/VBN
tuberculosis/NN
drugs/NNS
suffer/VBP
gastritis/NN
more/RBR
than/IN
normal/JJ
subjects/NNS
./.
====================
This/DT
gives/VBZ
information/NN
on/IN
the/DT
relation/NN
between/IN
gastritis/NN
and/CC
tuberculosis/NN
in/IN
females/NNS
./.
====================
ROC/NN
curves/NNS
can/MD
show/VB
how/WRB
gastritis-associated/VBN
factors/NNS
of/IN
Tables/NNS
1/CD
and/CC
2/CD
affect/VB
gastritis/NN
patients/NNS
and/CC
normal/JJ
subjects/NNS
./.
====================
Whether/IN
these/DT
factors/NNS
are/VBP
conclusive/JJ
should/MD
be/VB
confirmed/VBN
by/IN
AUC/NN
values/NNS
./.
====================
Figs/NNS
./.
====================
1/CD
and/CC
2/CD
are/VBP
ROC/NN
curves/NNS
using/VBG
the/DT
result/NN
of/IN
the/DT
logistic/JJ
regression/NN
test/NN
of/IN
Tables/NNS
1/CD
and/CC
2/CD
,/,
respectively/RB
./.
====================
Each/DT
AUC/NN
value/NN
is/VBZ
0.697/CD
and/CC
0.687/CD
./.
====================
This/DT
result/NN
means/NNS
that/DT
these/DT
factors/NNS
are/VBP
not/RB
useful/JJ
as/IN
gastric-specific/JJ
markers/NNS
./.
====================
Genome-wide/NN
association/NN
studies/NNS
====================
We/PRP
selected/VBD
the/DT
top/NN
20/CD
ranked/VBD
SNPs/NNS
by/IN
association/NN
test/NN
using/VBG
chi-square/JJ
test/NN
and/CC
p-values/NNS
among/IN
349,184/CD
SNPs/NNS
in/IN
males/NNS
and/CC
in/IN
females/NNS
,/,
respectively/RB
./.
====================
The/DT
results/NNS
of/IN
SNPs/NNS
association/NN
analysis/NN
described/VBN
in/IN
Tables/NNS
3/CD
and/CC
4/CD
./.
====================
Tables/NNS
3/CD
and/CC
4/CD
are/VBP
top/NN
20/CD
ranked/VBD
SNPs/NNS
of/IN
genomewide/NN
association/NN
analysis/NN
in/IN
males/NNS
and/CC
females/NNS
,/,
respectively/RB
./.
====================
They/PRP
are/VBP
sorted/VBN
by/IN
P-value/JJ
./.
====================
But/CC
there/EX
was/VBD
no/DT
considerable/JJ
SNP/NN
associated/VBN
with/IN
gastritis/NN
./.
====================
Astonishingly/RB
,/,
there/EX
was/VBD
no/DT
common/JJ
SNP/NN
between/IN
males/NNS
and/CC
females/NNS
./.
====================
This/DT
means/NNS
that/DT
associated-SNPs/NNS
are/VBP
different/JJ
,/,
depending/VBG
on/IN
the/DT
patient/NN
's/POS
gender/NN
./.
====================
Table/JJ
5/CD
describes/VBZ
the/DT
important/JJ
SNPs/NNS
associated/VBN
with/IN
gastritis/NN
by/IN
logistic/JJ
regression/NN
analysis/NN
among/IN
the/DT
top/NN
20/CD
ranked/VBD
SNPs/NNS
./.
====================
The/DT
p-values/NNS
of/IN
these/DT
SNPs/NNS
were/VBD
all/DT
</JJR
0.001/CD
./.
====================
Figs/NNS
./.
====================
3/CD
and/CC
4/CD
show/VBP
the/DT
ROC/NN
curve/NN
by/IN
using/VBG
these/DT
SNPs/NNS
in/IN
males/NNS
and/CC
in/IN
females/NNS
,/,
respectively/RB
./.
====================
The/DT
AUC/NN
scores/VBZ
are/VBP
0.675/CD
and/CC
0.658/CD
in/IN
males/NNS
and/CC
in/IN
females/NNS
,/,
respectively/RB
./.
====================
The/DT
AUC/NN
score/RB
was/VBD
too/RB
low/JJ
to/TO
use/VB
as/IN
a/DT
specific/JJ
factor/NN
for/IN
diagnosis/NN
./.
====================
In/IN
this/DT
study/NN
,/,
we/PRP
confirmed/VBD
that/IN
vascular/JJ
disease/NN
and/CC
gastritis/NN
have/VBP
considerable/JJ
association/NN
in/IN
Korean/JJ
males/NNS
./.
====================
We/PRP
also/RB
verified/VBN
that/DT
gastritis/NN
is/VBZ
affected/VBN
by/IN
other/JJ
various/JJ
drugs/NNS
./.
====================
However/RB
,/,
we/PRP
could/MD
not/RB
find/VB
gastritis-specific/JJ
biomarkers/NNS
for/IN
diagnosis/NN
./.
====================
Gastritis/NN
has/VBZ
numerous/JJ
causes/VBZ
and/CC
is/VBZ
distributed/VBN
as/IN
variable/JJ
subtypes/NNS
by/IN
phenotype/NN
./.
====================
So/RB
,/,
correctly/RB
diagnosing/VBG
it/PRP
is/VBZ
very/RB
important/JJ
for/IN
therapy/NN
./.
====================
Gastritis/NN
has/VBZ
non-specific/JJ
phenotypes/NNS
that/IN
can/MD
obscure/VB
finding/NN
the/DT
disease/NN
causes/VBZ
./.
====================
So/RB
,/,
more/RBR
information/NN
is/VBZ
also/RB
needed/VBD
to/TO
analyze/VB
the/DT
complex/NN
factors/NNS
associated/VBN
with/IN
disease/NN
rather/RB
than/IN
each/DT
factor/NN
associated/VBN
with/IN
the/DT
disease/NN
./.
====================
For/IN
example/NN
,/,
confirmation/NN
of/IN
H./NNP
pylori/NN
infection/NN
,/,
tobacco/NN
,/,
smoking/NN
period/NN
,/,
and/CC
alcohol/NN
intake/NN
are/VBP
considered/VBN
./.
====================
This/DT
needs/VBZ
further/RBR
study/NN
./.
====================
Receiver/RB
operating/VBG
characteristic/JJ
(/(
ROC/NN
)/)
curve/VBP
of/IN
gastritis-associated/JJ
factors/NNS
in/IN
males/NNS
./.
====================
This/DT
shows/VBZ
how/WRB
well/RB
the/DT
22/CD
gastritis-associated/VBN
clinical/JJ
characteristic/JJ
factors/NNS
(/(
Table/JJ
1/CD
)/)
classify/VBP
patients/NNS
and/CC
normal/JJ
subjects/NNS
in/IN
males/NNS
./.
====================
As/IN
much/RB
as/IN
the/DT
ROC/NN
curve/NN
,/,
these/DT
factors/NNS
can/MD
classify/VB
gastritis/NN
patients/NNS
and/CC
normal/JJ
subjects/NNS
in/IN
males/NNS
./.
====================
Receiver/RB
operating/VBG
characteristic/JJ
(/(
ROC/NN
)/)
curve/VBP
of/IN
gastritis-associated/JJ
factors/NNS
in/IN
females/NNS
./.
====================
This/DT
shows/VBZ
how/WRB
well/RB
the/DT
26/CD
gastritis-associated/VBN
clinical/JJ
characteristic/JJ
factors/NNS
(/(
Table/JJ
2/CD
)/)
classify/VBP
patients/NNS
and/CC
normal/JJ
subjects/NNS
in/IN
females/NNS
./.
====================
As/IN
much/RB
as/IN
the/DT
ROC/NN
curve/NN
,/,
these/DT
factors/NNS
can/MD
classify/VB
gastritis/NN
patients/NNS
and/CC
normal/JJ
subjects/NNS
in/IN
females/NNS
./.
====================
Receiver/RB
operating/VBG
characteristic/JJ
(/(
ROC/NN
)/)
curve/VBP
of/IN
gastritis-associated/JJ
single-nucleotide/JJ
polymorphisms/NNS
(/(
SNPs/NNS
)/)
in/IN
males/NNS
./.
====================
This/DT
shows/VBZ
how/WRB
well/RB
20/CD
ranked/VBD
gastritis-associated/VBN
SNPs/NNS
(/(
Table/JJ
3/CD
)/)
classify/VBP
patients/NNS
and/CC
normal/JJ
subjects/NNS
in/IN
males/NNS
./.
====================
As/IN
much/RB
as/IN
the/DT
ROC/NN
curve/NN
,/,
these/DT
factors/NNS
can/MD
classify/VB
gastritis/NN
patients/NNS
and/CC
normal/JJ
subjects/NNS
in/IN
males/NNS
./.
====================
Receiver/RB
operating/VBG
characteristic/JJ
(/(
ROC/NN
)/)
curve/VBP
of/IN
gastritis-associated/JJ
single-nucleotide/JJ
polymorphisms/NNS
(/(
SNPs/NNS
)/)
in/IN
females/NNS
./.
====================
This/DT
shows/VBZ
how/WRB
well/RB
20/CD
ranked/VBD
gastritis-associated/VBN
SNPs/NNS
(/(
Table/JJ
4/CD
)/)
classify/VBP
patients/NNS
and/CC
normal/JJ
subjects/NNS
in/IN
females/NNS
./.
====================
As/IN
much/RB
as/IN
the/DT
ROC/NN
curve/NN
,/,
these/DT
factors/NNS
can/MD
classify/VB
gastritis/NN
patients/NNS
and/CC
normal/JJ
subjects/NNS
in/IN
females/NNS
./.
====================
Clinical/JJ
characteristics/NNS
of/IN
gastritis/NN
variables/NNS
in/IN
male/JJ
====================
Clinical/JJ
characteristics/NNS
of/IN
gastritis/NN
variables/NNS
in/IN
female/JJ
====================
Top/RB
20/CD
ranked/VBD
SNPs/NNS
of/IN
genomewide/NN
association/NN
analysis/NN
in/IN
males/NNS
====================
Top/RB
20/CD
ranked/VBD
SNPs/NNS
of/IN
genomewide/NN
association/NN
analysis/NN
in/IN
females/NNS
====================
Gastritis-associated/JJ
single-nucleotide/JJ
polymorphisms/NNS
====================
